Asenapine treatment of bipolar mania in a randomized, double-blind, placebo- and olanzapine-controlled trial (ARES 7501005)

被引:0
|
作者
Hirschfeld, R. [1 ]
Panagides, J. [2 ]
Alphs, L. [3 ]
Cohen, M. [2 ]
Lancaster, S. [3 ]
Macek, T. [3 ]
机构
[1] Univ Texas Med Branch, Galveston, TX USA
[2] Organon Int Inc, Roseland, NJ USA
[3] Pfizer Global R&D, Ann Arbor, MI USA
关键词
acute mania; asenapine; bipolar disorder; efficacy;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:53 / 53
页数:1
相关论文
共 50 条
  • [21] Efficacy of olanzapine monotherapy for treatment of bipolar I depression: a randomized, double-blind, placebo controlled study
    Wang, Man
    Tong, Jian-hua
    Huang, De-sheng
    Zhu, Gang
    Liang, Guang-ming
    Du, Hong
    PSYCHOPHARMACOLOGY, 2014, 231 (14) : 2811 - 2818
  • [22] A randomized, double-blind, placebo-controlled study of olanzapine in patients with bipolar depression
    Tohen, M.
    McDonnell, D. P.
    Case, M.
    Kanba, S.
    Ha, K.
    Fang, Y.
    Katagiri, H.
    Gomez, J. C.
    BIPOLAR DISORDERS, 2011, 13 : 100 - 100
  • [23] Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder; A 3-week randomized double-blind placebo-controlled study
    Tohen, Mauricio
    Kryzhanovskaya, Ludmila
    Carlson, Gabrielle
    DelBello, Melissa
    Wozniak, Janet
    Kowatch, Robert
    Wagner, Karen
    Findling, Robert
    Lin, Daniel
    Robertson-Plouch, Carol
    Xu, Wen
    Dittmann, Ralf
    Biederman, Joe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2006, 15 : S301 - S302
  • [24] Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder; A 3-week randomized double-blind placebo-controlled study
    Tohen, M
    Kryzhanovskaya, L
    Carlson, G
    DelBello, M
    Wozniak, J
    Kowatch, R
    Wagner, K
    Findling, R
    Lin, D
    Robertson-Plouch, C
    Xu, W
    Huang, XH
    Dittmann, R
    Biederman, J
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 118S - 119S
  • [25] Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder: A 3-week randomized double-blind placebo-controlled study
    Tohen, M
    Kryzhanovskaya, L
    Carlson, G
    DelBello, M
    Wozniak, J
    Kowatch, R
    Wagner, K
    Findling, R
    Lin, D
    Robertson-Plouch, C
    Xu, W
    Huang, XH
    Dittman, R
    Biederman, J
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S176 - S177
  • [26] Asenapine versus olanzapine in acute mania: a double-blind extension study
    McIntyre, Roger S.
    Cohen, Miriam
    Zhao, Jun
    Alphs, Larry
    Macek, Thomas A.
    Panagides, John
    BIPOLAR DISORDERS, 2009, 11 (08) : 815 - 826
  • [27] Double-blind extension studies of asenapine in patients with bipolar mania
    McIntyre, R.
    Cohen, M.
    Zhao, J.
    Panagides, J.
    Szegedi, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S372 - S372
  • [28] Double-Blind Extension studies of Asenapine in patients with bipolar mania
    McIntyre, R.
    Cohen, M.
    Zhao, J.
    Panagides, J.
    Szegedi, A.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 183 - 183
  • [29] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF CLONIDINE IN THE TREATMENT OF ACUTE MANIA
    JANICAK, PG
    SHARMA, RP
    EASTON, M
    COMATY, JE
    DAVIS, JM
    PSYCHOPHARMACOLOGY BULLETIN, 1989, 25 (02) : 243 - 245
  • [30] Long-term double-blind extension studies of asenapine versus olanzapine in patients with bipolar mania
    McIntyre, R.
    Alphs, L.
    Cohen, M.
    Keller, D. S.
    Macek, T.
    Panagides, J.
    BIPOLAR DISORDERS, 2008, 10 : 49 - 49